U
Ulrich Klar
Researcher at Schering AG
Publications - 44
Citations - 367
Ulrich Klar is an academic researcher from Schering AG. The author has contributed to research in topics: Aryl & Alkyl. The author has an hindex of 9, co-authored 44 publications receiving 361 citations. Previous affiliations of Ulrich Klar include Hess Corporation.
Papers
More filters
Journal ArticleDOI
Total Synthesis and Antitumor Activity of ZK‐EPO: The First Fully Synthetic Epothilone in Clinical Development
Ulrich Klar,Bernd Buchmann,Wolfgang Schwede,Werner Skuballa,Jens Hoffmann,Rosemarie Lichtner +5 more
Journal ArticleDOI
New synthetic inhibitors of microtubule depolymerization
TL;DR: A new class of borneol esters that might be considered as biological analogs of paclitaxel regarding their action on microtubules has been found by structure-activity optimizations, and will open completely new therapeutic areas.
Patent
New epothilone derivatives
TL;DR: In this article, the Epothilone derivatives of formula (I) are new and are prepared from a number of new and known starting compounds, and they have the same meanings as R a, R b and R b, provided that when D-E is CH2-CH2 or Y is O, then R a and Rb are not H or CH3; R, R = H, 1-10C alkyl, aryl or 7-20C aralkyl, which are all optionally substituted.
Journal ArticleDOI
11β-Aryl steroids in the androstene series. The role of the 11β-region in steroid progesterone receptor interaction
Arwed Cleve,Karl-Heinrich Fritzemeier,Nikolaus Heinrich,Ulrich Klar,Anke Müller-Fahrnow,Günter Neef,Eckhard Ottow,Wolfgang Schwede +7 more
TL;DR: The conformation of 11β-arylandrostenes is discussed in comparison with known antiprogestational steroids and conformational changes of the steroid ring system that result in reduced affinity for the progesterone receptor are discussed.
Journal ArticleDOI
Beneficial effects of fluorine in the anti-progestin ZK 230211
TL;DR: A novel, highly potent progesterone receptor antagonist, ZK 230211, has been identified after introduction of a 17α-pentafluoroethyl side chain into the D-ring of the steroidal skeleton resulted in a compound that combines a pure anti-progestagenic endocrinological profile with high potency.